Showing results (1281-1290 of 2,669) with videos related to
Sort By:
Pageof 267
Oncology Research|January 8, 2024
Identification and validation of novel prognostic fatty acid metabolic gene signatures in colon adenocarcinoma through systematic approachesHeng Zhang, Wenjing Cheng, Haibo Zhao, et al.Oncology Research|January 8, 2024
Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cellsBehrooz Johari, Milad Parvinzad Leilan, Mahmoud Gharbavi, et al.Oncology Research|June 26, 2026
PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling PathwayLei Luo, Fengju Guan, Zhankun Wang, et al.Oncology Research|June 26, 2026
Dual Immune Checkpoint Blockade in Synchronous Hepatocellular and Renal Cell Carcinoma: A Real-World Case Report of Durable Dual ResponsePiera Federico, Maria Anna Canciello, Barbara Granata, et al.Oncology Research|June 26, 2026
Monoclonal Antibodies and Derivatives: Therapeutic Tools for CancerAlessandro PoggiOncology Research|June 26, 2026
Engineering the Future of ADCs in Non-Small Cell Lung CancerMi Rim Kim, Jason Lau, Michele Maffezzoli, et al.Oncology Research|June 26, 2026
Emerging Nanocarrier Strategies for Optimized Drug Delivery in the Treatment of Primary Bone CancerLindokuhle M Ngema, Samson A Adeyemi, Yahya E ChoonaraOncology Research|June 26, 2026
Autocrine Motility Factor-Derived Tetradecapeptides as Dual-Action Chemosensitizers: Bridging Cell Competition Mechanisms with Clinical MDR Reversal in Hematological MalignanciesChangyul Kim, Yu Ju Jung, Da Hee Son, et al.Oncology Research|June 26, 2026
Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic ImplicationsGuodong Yu, Weiying Ge, Hongliang Yao, et al.Oncology Research|June 26, 2026
Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic TargetJian-Lei Kang, Yu-Jie Xu, Qi-Tai Zhao, et al.Pageof 267